Diaceutics PLC (FRA:7DC)
€ 1.38 -0.05 (-3.5%) Market Cap: 119.03 Mil Enterprise Value: 100.30 Mil PE Ratio: 0 PB Ratio: 2.69 GF Score: 86/100

Half Year 2022 Diaceutics PLC Earnings Call Transcript

Sep 28, 2022 / 12:00PM GMT
Release Date Price: €1
Operator

Good afternoon, and welcome to the Diaceutics PLC Half Year Results Investor Presentation.(Operator Instructions) Before we begin, we'd like to submit the following poll.

I'd now like to hand over to Nick Roberts, CFO; and Peter Keeling, CEO. Good afternoon.

Peter Keeling
Diaceutics PLC - Founder, CEO & Executive Director

Good afternoon. Thanks very much indeed, Paul. And indeed welcome as Paul said, to the webinar. And so as myself and Nick presenting. Nick, just as a reminder, joined the company some 6 months or so ago, and he's certainly been working diligently to introduce a couple of new KPIs, which we will feature in the deck today. And I'm going to walk you through a brief introduction through changes in the market space, what we've been doing for the last sort of 6 months. And Nick will then hand over -- I'll hand over to Nick and he'll take you through the kind of the key financials at the headline stage, and then we'll come back and look, take a little look forward as to where the business is going.

We move on to the first

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot